Undergraduate - UnitPAC2412 - Integrated therapeutics: Introduction and cardiovascular

This unit entry is for students who completed this unit in 2013 only. For students planning to study the unit, please refer to the unit indexes in the the current edition of the Handbook. If you have any queries contact the managing faculty for your course or area of study.

print version

6 points, SCA Band 2, 0.125 EFTSL

To find units available for enrolment in the current year, you must make sure you use the indexes and browse unit tool in the current edition of the Handbook.

Level	Undergraduate
Faculty	Faculty of Pharmacy and Pharmaceutical Sciences
Offered	Sunway Second semester 2013 (Day) Parkville Second semester 2013 (Day)
Coordinator(s)	Associate Professor Simon Bell (Parkville); Mr Benny Efendie (Sunway)

Synopsis

This unit provides an introduction to disease state management. It will cover concepts that span the range of diseases such as issues related to the management of paediatric and geriatric patients and the use and interpretation of laboratory tests for diagnosis and monitoring.

This unit provides a foundation of basic knowledge required for the diagnosis and management of patients with cardiovascular diseases. It will relate the pathophysiology of these disorders with the rational design and clinical use of drugs. The chemistry, pharmacology and clinical aspects of medications associated with each area are presented in detail in an integrated fashion.

This will involve:

introduction to disease state management
epidemiology and pathophysiology of cardiovascular disease
chemistry of drugs used in cardiovascular disease
pharmacology of drugs used in cardiovascular disease
cardiovascular disease state management.

Outcomes

At the end of this unit students will be able to:

Describe the epidemiology and concepts of disease state management of cardiovascular diseases including the concepts affecting the management of various types of patients (e.g. paediatric and geriatric patients);
Evaluate a patient's laboratory test results to assist with the diagnosis or management of disease;
Describe the normal function of the cardiovascular system and the signs and symptoms likely to be seen in patients with the disorders;
Recognise when referral for medical assessment is required with a particular emphasis on cardinal symptoms;
Relate modifications of physiological and molecular mechanisms to the observed disorder;
Describe the chemistry of the different types of drugs used to treat these disorders and the chemical and biological principals behind the development of a range of drugs used to treat these disorders;
Describe drug and non-drug therapy options for the management of cardiovascular disease and primary and secondary prevention strategies for cardiovascular disease;
Evaluate a patient's disease state, identify any drug therapy problems and recommend appropriate resolutions of those problems;
Formulate a medical management program for specific patients based on their medical, medication and psychosocial histories and laboratory test results;
Apply basic counselling strategies that optimize behavioural change support for patients with chronic conditions.

Assessment

Final exam (3 hour): 70%; practical assessments: 15%; assessment of self-directed learning: 15%.

Chief examiner(s)

Associate Professor Simon Bell

Contact hours

Contact hours for on-campus students:
Thirty six 1-hour lectures
One 2-hour practical class
Two 3 hour practical classes

Co-requisites

PAC2182 Basis of drug action II

Additional information on this unit is available from the faculty at:

http://www.monash.edu/pharm/current/